The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM)
- PMID: 10961570
- DOI: 10.1016/s1386-5056(00)00062-9
The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM)
Abstract
The Medical Dictionary for Regulatory Activities Terminology (MedDRA) version 2.1 (V2.1) was released in March 1999 accompanied by the MedDRA/J V2.1J specifically for Japanese users. In prescription-event monitoring in Japan (J-PEM), we have employed the MedDRA/J for data entry, signal generation and event listing. In J-PEM, the lowest level terms (LLTs) in the MedDRA/J are used in data entry because the richness of LLTs is judged to be advantageous. A signal is generated normally at the preferred term (PT) level, but it has been found that various reporters describe the same event using descriptions that are potentially encoded by LLTs under different PTs. In addition, some PTs are considered too specific to generate the proper signal. In the system used in J-PEM, when an LLT is selected as a candidate to encode an event, another LLT under a different PT, if any, is displayed on the computer screen so that it may be coded instead of, or in addition to, the candidate LLT. The five-level structure of the MedDRA is used when listing events but some modification is required to generate a functional event list.
Similar articles
-
Prescription-event monitoring in Japan (J-PEM).Drug Saf. 2002;25(6):441-4. doi: 10.2165/00002018-200225060-00008. Drug Saf. 2002. PMID: 12071781
-
Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.Drug Saf. 2005;28(1):19-34. doi: 10.2165/00002018-200528010-00002. Drug Saf. 2005. PMID: 15649103
-
Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART.Drug Saf. 2002;25(6):445-52. doi: 10.2165/00002018-200225060-00009. Drug Saf. 2002. PMID: 12071782
-
The medical dictionary for regulatory activities (MedDRA).Drug Saf. 1999 Feb;20(2):109-17. doi: 10.2165/00002018-199920020-00002. Drug Saf. 1999. PMID: 10082069 Review.
-
Using MedDRA: implications for risk management.Drug Saf. 2004;27(8):591-602. doi: 10.2165/00002018-200427080-00010. Drug Saf. 2004. PMID: 15154830 Review.
Cited by
-
Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches.Front Pharmacol. 2019 May 17;10:415. doi: 10.3389/fphar.2019.00415. eCollection 2019. Front Pharmacol. 2019. PMID: 31156424 Free PMC article.
-
A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms.BMC Med Inform Decis Mak. 2008 Oct 27;8 Suppl 1(Suppl 1):S4. doi: 10.1186/1472-6947-8-S1-S4. BMC Med Inform Decis Mak. 2008. PMID: 19007441 Free PMC article.
-
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.Drug Saf. 2000 Dec;23(6):533-42. doi: 10.2165/00002018-200023060-00004. Drug Saf. 2000. PMID: 11144660
-
A knowledge graph of clinical trials ([Formula: see text]).Sci Rep. 2022 Mar 18;12(1):4724. doi: 10.1038/s41598-022-08454-z. Sci Rep. 2022. PMID: 35304504 Free PMC article.
-
Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study.Drug Healthc Patient Saf. 2013 Jun 24;5:143-50. doi: 10.2147/DHPS.S45347. Print 2013. Drug Healthc Patient Saf. 2013. PMID: 23843704 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials